CHRONIC HEPATITIS B
Clinical trials for CHRONIC HEPATITIS B explained in plain language.
Never miss a new study
Get alerted when new CHRONIC HEPATITIS B trials appear
Sign up with your email to follow new studies for CHRONIC HEPATITIS B, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New pill targets hepatitis b virus in early human trial
Disease control CompletedThis early-stage study tested a new oral drug, ALG-000184, to see if it is safe and can reduce the hepatitis B virus in people with a chronic infection. The trial first gave the drug to healthy volunteers to check safety, then gave it to patients with hepatitis B, both alone and …
Matched conditions: CHRONIC HEPATITIS B
Phase: PHASE1 • Sponsor: Aligos Therapeutics • Aim: Disease control
Last updated Apr 03, 2026 22:41 UTC
-
First human tests for new hepatitis b vaccines show promise
Disease control CompletedThis early-stage study tested the safety of two new therapeutic vaccines, GS-2829 and GS-6779, in healthy volunteers and people with chronic hepatitis B. The main goal was to see if the vaccines were safe and well-tolerated, and to measure the immune response they triggered again…
Matched conditions: CHRONIC HEPATITIS B
Phase: PHASE1 • Sponsor: Gilead Sciences • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
New injection tested to fight chronic hepatitis b
Disease control CompletedThis study tested an experimental injection called RBD1016 in adults with chronic hepatitis B who were already taking standard antiviral pills. Researchers wanted to see if adding this injection was safe and could further reduce signs of the hepatitis B virus in the blood. The tr…
Matched conditions: CHRONIC HEPATITIS B
Phase: PHASE2 • Sponsor: Suzhou Ribo Life Science Co. Ltd. • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New drug combo shows promise in fighting stubborn hepatitis b
Disease control CompletedThis study tested whether adding an experimental drug called AB-729 to standard hepatitis B medications could better control the virus. Researchers enrolled 43 people with chronic hepatitis B who were already taking antiviral drugs. They wanted to see if this combination was safe…
Matched conditions: CHRONIC HEPATITIS B
Phase: PHASE2 • Sponsor: Arbutus Biopharma Corporation • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
Scientists test genetic vaccine to reboot immune system against stubborn hepatitis b
Disease control CompletedThis early-stage study tested whether a new type of vaccine made from DNA could safely help the body's immune system fight chronic hepatitis B. It involved 10 patients whose infections had not responded to standard medications. The main goal was to check if the vaccine was safe a…
Matched conditions: CHRONIC HEPATITIS B
Phase: PHASE1 • Sponsor: Institut National de la Santé Et de la Recherche Médicale, France • Aim: Disease control
Last updated Mar 23, 2026 15:14 UTC
-
Researchers map hidden fat in hepatitis b patients
Knowledge-focused CompletedThis study aimed to understand how often fatty liver and fatty pancreas occur in people with chronic hepatitis B, comparing those who are obese to those who are lean. It involved 217 adult patients with hepatitis B. Researchers used special scans to measure fat in the liver and p…
Matched conditions: CHRONIC HEPATITIS B
Sponsor: Tanta University • Aim: Knowledge-focused
Last updated Mar 24, 2026 12:02 UTC